Correction: Modified CAR T cells targeting membrane-proximal epitope of mesothelin enhances the antitumor function against large solid tumor

Correction to: Cell Death and Disease

10.1038/s41419-019-1711-1

published online 17 June 2019

In the original published version of the article, the following information was omitted from the Methods section. The second paragraph should have read as follows:

Generation of modified CAR T cells

The meso3 CAR gene was cloned into the PB transposon vector pNB328-EF1α to construct pNB328-meso3 CAR. pNB328-meso1 CAR and empty pNB328 vectors were used as controls. The antibody sequence for Meso3 CAR T was derived from the YP218 antibody, which was originally discovered by the NIH (https://www.nature.com/articles/srep09928; US Patent: US9803022: https://patents.google.com/patent/US9803022). In addition, the antibody sequence for Meso1 CAR T was derived from the SS1 antibody, which was also originally discovered by the NIH (US Patent: US7081518: https://patents.google.com/patent/US7081518?oq=patent:7081518).

This has been corrected in both the PDF and HTML versions of the Article.